Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Plos One|July 6, 2018
A multi-centre investigation of delivering national guidelines on exercise training for men with advanced prostate cancer undergoing androgen deprivation therapy in the UK NHSLiam Bourke, Rebecca Turner, Rosa Greasley, et al.
Critical Reviews in Oncology/Hematology|March 18, 2011
Consensus on the utility of bone markers in the malignant bone disease settingRobert Coleman, Luis Costa, Fred Saad, et al.
Multiple Sclerosis and Related Disorders|May 18, 2021
Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosisStephanie N Blandford, Dylan A Galloway, John B Williams, et al.
BMC Health Services Research|March 26, 2021
The development of a theory and evidence-based intervention to aid implementation of exercise into the prostate cancer care pathway with a focus on healthcare professional behaviour, the STAMINA trialRebecca R Turner, Madelynne A Arden, Sophie Reale, et al.
Journal of Public Health Management and Practice : JPHMP|August 29, 2022
Resource Savings Associated With Use of an Automated Symptom Monitoring Tool for COVID-19 Public Health Response, Summer 2020-Summer 2021Kellen F Sweeney, Heather M Halter, Kerry Krell, et al.
Journal of the Academy of Nutrition and Dietetics|October 23, 2013
Predictors of sustained reduction in energy and fat intake in the Diabetes Prevention Program Outcomes Study intensive lifestyle interventionNichola J Davis, Yong Ma, Linda M Delahanty, et al.
BMC Cancer|December 18, 2012
The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renal cancerFiona J Collinson, Walter M Gregory, Chris McCabe, et al.
Journal of the National Cancer Institute|February 10, 2018
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) TrialJanet Brown, Emma Rathbone, Samantha Hinsley, et al.
Journal of Bone Oncology|July 8, 2022
A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases: CARBON trial resultsMatthew Winter, Rob Coleman, Jessica Kendall, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 3, 2015
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastasesRoger von Moos, Jean-Jacques Body, Blair Egerdie, et al.
Pageof 9